MCID: CHR583
MIFTS: 39
|
Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb
Categories:
Fetal diseases, Genetic diseases, Rare diseases
|
|
MalaCards integrated aliases for Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb:
Characteristics:Orphanet epidemiological data:58
1q21.1 microdeletion syndrome
Inheritance: Autosomal dominant,Not applicable; Age of onset: Infancy,Neonatal; OMIM®:57 (Updated 05-Mar-2021)
Miscellaneous:
incomplete penetrance
Inheritance:
autosomal dominant isolated cases HPO:31
chromosome 1q21.1 deletion syndrome, 1.35-mb:
Inheritance autosomal dominant inheritance sporadic Onset and clinical course incomplete penetrance Classifications:
ICD10:
32
33
Orphanet: 58
![]() |
MedlinePlus Genetics :
43
1q21.1 microdeletion is a chromosomal change in which a small piece of chromosome 1 is deleted in each cell. The deletion occurs on the long (q) arm of the chromosome in a region designated q21.1. This chromosomal change increases the risk of delayed development, intellectual disability, physical abnormalities, and neurological and psychiatric problems. However, some people with a 1q21.1 microdeletion do not appear to have any associated features.About 75 percent of all children with a 1q21.1 microdeletion have delayed development, particularly affecting the development of motor skills such as sitting, standing, and walking. The intellectual disability and learning problems associated with this genetic change are usually mild.Distinctive facial features can also be associated with 1q21.1 microdeletions. The changes are usually subtle and can include a prominent forehead; a large, rounded nasal tip; a long space between the nose and upper lip (philtrum); and a high, arched roof of the mouth (palate). Other common signs and symptoms of 1q21.1 microdeletions include an unusually small head (microcephaly), short stature, and eye problems such as clouding of the lenses (cataracts). Less frequently, 1q21.1 microdeletions are associated with heart defects, abnormalities of the genitalia or urinary system, bone abnormalities (particularly in the hands and feet), and hearing loss.Neurological problems that have been reported in people with a 1q21.1 microdeletion include seizures and weak muscle tone (hypotonia). Psychiatric or behavioral problems affect a small percentage of people with this genetic change. These include developmental conditions called autism spectrum disorders that affect communication and social interaction, attention-deficit/hyperactivity disorder (ADHD), and sleep disturbances. Studies suggest that deletions of genetic material from the 1q21.1 region may also be risk factors for schizophrenia.Some people with a 1q21.1 microdeletion do not have any of the intellectual, physical, or psychiatric features described above. In these individuals, the microdeletion is often detected when they undergo genetic testing because they have a relative with the chromosomal change. It is unknown why 1q21.1 microdeletions cause cognitive and physical changes in some individuals but few or no health problems in others, even within the same family.
MalaCards based summary : Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb, also known as chromosome 1q21.1 deletion syndrome, is related to thrombocytopenia-absent radius syndrome and thrombocytopenia. An important gene associated with Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb is DEL1Q21 (Chromosome 1q21.1 Deletion Syndrome). Affiliated tissues include eye, brain and heart, and related phenotypes are intellectual disability and frontal bossing Disease Ontology : 12 A chromosomal deletion syndrome that has material basis in a contiguous deletion of the 1q21.1 region on chromosome 1 and is characterized by an increases the risk of delayed development, intellectual disability, physical abnormalities, and neurological and psychiatric problems. GARD : 20 1q21.1 microdeletion syndrome is a chromosome abnormality where a segment of genetic material on the long arm (or q arm) of chromosome 1 at position 21.1 is missing (or deleted). Some people with this deletion have no observable features while others have variable findings that can include a small head (microcephaly), developmental delay (speech and motor delays), mild intellectual disability, distinctive facial features, and eye abnormalities. Other findings can include seizures as well as abnormalities of the heart, skeleton, and urinary system. Psychiatric and behavioral features can include autism spectrum disorders, anxiety and mood disorders, schizophrenia, attention deficit hyperactivity disorder and sleep disorders. This syndrome is caused by a deletion in a specific region of 1q21.1, which is distinct from the deletion region that causes TAR syndrome. Wikipedia : 74 1q21.1 deletion syndrome is a rare aberration of chromosome 1. A human cell has one pair of identical... more...
More information from OMIM:
612474
|
Human phenotypes related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb:58 31 (show top 50) (show all 54)
Symptoms via clinical synopsis from OMIM®:57 (Updated 05-Mar-2021)Clinical features from OMIM®:612474 (Updated 05-Mar-2021) |
Interventional clinical trials:
|
MalaCards organs/tissues related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb:40
Eye,
Brain,
Heart
|
Articles related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb:(show all 16)
|
ClinVar genetic disease variations for Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb:6
|
Search
GEO
for disease gene expression data for Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb.
|
Cellular components related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb according to GeneCards Suite gene sharing:
Biological processes related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb according to GeneCards Suite gene sharing:
Molecular functions related to Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb according to GeneCards Suite gene sharing:
|
|